DCM
AMED

Davidson Capital Management’s Amedisys AMED Stock Holding History

Davidson Capital Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-15
Closed -$3K – 83
2022
Q1 		$3K Sell
15
-2
-12% -$299 ﹤0.01% 63
2021
Q4 		$3K Sell
17
-5,048
-100% -$811K ﹤0.01% 73
2021
Q3 		$755K Buy
5,065
+338
+7% +$70.3K 0.38% 71
2021
Q2 		$1.16M Buy
4,727
+715
+18% +$188K 0.56% 63
2021
Q1 		$1.06M Buy
4,012
+613
+18% +$173K 0.55% 65
2020
Q4 		$997K Buy
3,399
+89
+3% +$22.8K 0.56% 32
2020
Q3 		$783K Sell
3,310
-554
-14% -$126K 0.5% 38
2020
Q2 		$767K Buy
3,864
+215
+6% +$40.1K 0.68% 40
2020
Q1 		$670K Buy
+3,649
New +$649K 0.96% 26

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Davidson Capital Management's AMED Position: Q2 2022 in Review

Davidson Capital Management sold out of Amedisys (AMED) in Q2 2022, closing a stake of 15 shares — an estimated $3K sold.

Davidson Capital Management first reported a position in AMED in Q1 2020 and held it in 9 quarters. The position peaked at $1.16M in Q2 2021. 289 funds tracked by Wall St. Rank hold AMED as of Q2 2022.

  • Davidson Capital Management reported no remaining Amedisys position as of Q2 2022 after selling out during the quarter.
  • Davidson Capital Management sold 15 Amedisys shares in Q2 2022, an estimated $3K.
  • Davidson Capital Management first reported a position in Amedisys in Q1 2020 and held it in 9 quarters.
  • Davidson Capital Management's Amedisys position peaked at $1.16M in Q2 2021.
  • 289 funds tracked by Wall St. Rank held Amedisys as of Q2 2022.

Based on Davidson Capital Management's 13F filing for Q2 2022, filed 17 Aug 2022.